Description
IPOL (Inactivated Poliomyelitis Vaccine, IPV) 0.5mL Prefilled Syringe Compact Single - Box of 1
This is a restricted schedule drug. Only to be sold to medical professionals. You will be required to provide your APHRA Registration Number/Scheduled Drug License.
A monovalent, inactivated poliovirus vaccine for active immunisation against polio in infants, children and adults. Registered in Australia and supplied as a single-dose 0.5 mL prefilled syringe for subcutaneous (SC) administration.
Key features
-
Indication & age: Active immunisation against poliomyelitis; registered for use from ≥2 months of age (refer to the Australian Immunisation Handbook for schedule specifics).
-
Dose & route: 0.5 mL SC. PI guidance: primary series of three 0.5 mL doses at ~8-week intervals; a booster at 4 years; adults at continuing risk may receive a booster about every 10 years. Follow local programs/Handbook.
-
Presentation: 1 × 0.5 mL prefilled syringe (single dose).
Composition & excipients (per 0.5 mL)
D-antigen units: type 1 (Mahoney) 28, type 2 (MEF-1) 7, type 3 (Saukett) 26. Excipients include phenoxyethanol (≈2–3 µL), formaldehyde (≈2–20 µg) and polysorbate 80; may contain traces of neomycin, streptomycin, polymyxin B and bovine serum albumin.
Storage & handling
-
Store at 2–8 °C. Do not freeze.
-
Shelf-life: up to 36 months at 2–8 °C.
-
Do not mix with other products in the same syringe.
Regulatory
ARTG ID: 47217 • Sponsor: Sanofi-Aventis Australia Pty Ltd. PI/CMI available via TGA. Therapeutic Goods Administration (TGA)
For detailed schedule, co-administration and clinical considerations, consult the Australian Immunisation Handbook and the current Product Information.
